Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer

Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer

Recent advances in immunotherapy have reshaped the clinical management of lung cancer, and immune checkpoint inhibitors (ICIs) are now first-line treatment for advanced lung cancer. However, the majority of patients do not respond to ICIs as single agents, and many develop resistance after initial r...

Full description

Bibliographic Details
Main Authors: Pasquale Saggese, Cesar A. Martinez, Linh M. Tran, Raymond Lim, Camelia Dumitras, Tristan Grogan, David Elashoff, Ramin Salehi-Rad, Steven M. Dubinett, Bin Liu, Claudio Scafoglio
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
cancer immunotherapy
murine models
lung cancer
Online Access:https://www.mdpi.com/2072-6694/13/14/3595

Internet

https://www.mdpi.com/2072-6694/13/14/3595

Similar Items